FDA Inspection
Viatris Pharmaceuticals LLCViatris Pharmaceuticals LLC – FDA Inspection, Feb 17, 2022
Record Details
This FDA Inspection record concerns Viatris Pharmaceuticals LLC, with an inspection on February 17, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Viatris Pharmaceuticals LLC
- Inspection Date
- February 17, 2022
- Product Type
- Drugs
View Company Profile
ID · a959367a-edd4-4db2-9a2a-ef57394f77ac
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1162864
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
1- 21 CFR 211.165(a)Testing and release for distribution
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Viatris Pharmaceuticals LLC
9| Date | Classification | Office | Project area |
|---|---|---|---|
| May 18, 2026 | Not classified | San Juan District Office | Drug Quality Assurance |
| January 26, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 26, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 19, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 11, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Viatris Pharmaceuticals LLC
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.